Pay in 4 interest-free payments of $7.15 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Common contraindications cited in the research-use community include: anyone with active or recent cancer (BPC-157 and TB-500 promote angiogenesis), people with Wilson's disease or other copper-metabolism disorders (GHK-Cu component), anyone pregnant or breastfeeding (no safety data), and athletes subject to WADA testing (BPC-157 and TB-500 are prohibited)
A diagnostic-use formulation (0.05 mg base per ampule, for evaluating the pituitary's capacity to secrete growth hormone) was approved December 28, 1990 under NDA 19-863
Administer subcutaneously in the abdomen or near the area of concern once or twice daily
This article is for educational purposes only and is not a substitute for medical advice, diagnosis, or treatment
No human trial data for this specific combination
US$ 29.85
US$ 24.82
US$ 25.40
